• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • DUPROST
    / Taro International Ltd


    Active Ingredient *
    Dutasteride 0.5 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Hard Capsules

    30 X 0.4/0.5 mg

    partial basket chart

    Related information


    Dosage

    The standard dosage is generally one capsule taken once a day, 30 minutes after the same meal each day.
    Please refer to the license holder for further details.


    Indications

    Treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH). Reduction in the risk of acute urinary retention (AUR) and surgery in patients with moderate to severe symptoms of BPH.


    Contra-Indications

    * Hypersensitivity to dutasteride, other 5-alpha reductase inhibitors, tamsulosin (including tamsulosin-induced angio-edema), soya, peanut or any of the other excipients.
    * History of orthostatic hypotension.
    * Severe hepatic impairment.
    * Women, children and adolescents.


    Special Precautions

    Please refer to the license holder for further details.


    Side Effects

    Please refer to the license holder for further details.


    Drug interactions

    Please refer to the license holder for further details.


    Pregnancy and Lactation

    Please refer to the license holder for further details.


    Overdose

    Please refer to the license holder for further details.

    סרגל נגישות

    CLOSE